Publications

5532 Results

Phase III randomized study of radiotherapy plus PCV with or without BUdR for the treatment of anaplastic astrocytoma RTOG 9404 interim report

Authors
M Prados;C Scott;T Phillips;R Davis;H Sandler;J Buckner;W Curran;C Schultz;R Urtason
Journal / Conference
Int J Radiat Oncol Biol Phys 39(2):138(#8)
Year
1997
Research Committee(s)
Brain
Study Number(s)
SWOG-9340 (RTOG-9404)

Phase III randomized study of radiotherapy plus PCV with or without BUdR for the treatment of anaplastic astrocytoma: RTOG 9404

Authors
M Prados;C Scott;T Phillips;R Davis;H Sandler;J Buckner;W Curran;C Schultz;R Urtasun
Journal / Conference
Proc of the Society for Neuro-Oncology, booklet:112
Year
1997
Research Committee(s)
Brain
Study Number(s)
SWOG-9340 (RTOG-9404)

Watchful Waiting for Localized Prostate Cancer

Authors
J Adolfsson;M Austenfeld;I Thompson
Journal / Conference
In: Principles of Urologic Oncology, (eds.) Lange P, Raghavan D, Scher H., J.B. Lippincott, Inc., Philadelphia, 1997
Year
1997
Research Committee(s)
Genitourinary

A randomized investigation of high-dose versus standard-dose cytosine arabinoside with daunorubicin in patients with previously untreated acute myeloid leukemia: A Southwest Oncology Group study.

Authors
JK Weick;KJ Kopecky;FR Appelbaum;DR Head;LL Kingsbury;SP Balcerzak;JN Bickers;HE Hynes;JL Welborn;SR Simon;M Grever
Journal / Conference
Blood 88(8):2841-2851
Year
1996
Research Committee(s)
Leukemia
Study Number(s)
SWOG-8600

Phase II trial of low-dose N-(phosphonacetyl)-disodium L-aspartic acid and high-dose 24-hour infusional 5-fluorouracil in advanced gastric adenocarcinoma: A Southwest Oncology Group study.

Authors
RL Martino;TR Fleming;LM Morrell;B Ardalan;SP Richman;JS Macdonald
Journal / Conference
Investigational New Drugs 14:419-421
Year
1996
Research Committee(s)
Gastrointestinal
Study Number(s)
SWOG-8734

Combination transurethral resection, systemic chemotherapy, and pelvic radiotherapy for invasive (T2-T4) bladder cancer unsuitable for cystectomy: A Phase I/II Southwestern Oncology Group study.

Authors
AB Einstein Jr;M Wolf;KR Halliday;GJ Miller;M Hafermann;BA Lowe;FJ Meyers;JT Leimert;ED Crawford
Journal / Conference
Urology 47(5):652-657
Year
1996
Research Committee(s)
Genitourinary
Study Number(s)
SWOG-8704

Phase III study of IP cisplatin plus IV cyclophosphamide vs IV cisplatin plus IV cyclophosphamide in optimal disease stage III ovarian cancer: An Intergroup study 0051 (SWOG-GOG-ECOG).

Authors
DS Alberts;PY Liu;EV Hannigan;R O'Toole;SD Williams;J Young;EW Franklin;D Clarke-Pearson;VK Malviya;B DuBeshter;W Hoskins;M Adelson;RD Alvarez;S Vogel;J O'Sullivan;DJ Garcia;D Sparks;ML Rothenberg
Journal / Conference
Society of Gynecologic Oncologists Abstract Book (#1):40
Year
1996
Research Committee(s)
Gynecologic
Study Number(s)
SWOG-8501 (INT-0051)

Evaluation of race as a prognostic factor in multiple myeloma: An ancillary of Southwest Oncology Group study 8829.

Authors
MR Modiano;P Villar-Werstler;J Crowley;SE Salmon
Journal / Conference
Journal of Clinical Oncology 14(3):974-977
Year
1996
Research Committee(s)
Myeloma
Study Number(s)
SWOG-8229/30

The addition of tamoxifen to dacarbazine and cisplatin in metastatic malignant melanoma. A phase II trial of the Southwest Oncology Group (SWOG-8921).

Authors
LE Flaherty;PY Liu;MS Mitchell;WS Fletcher;MJ Walker;JW Goodwin;RL Stephens;VK Sondak
Journal / Conference
American Journal of Clinical Oncology 19(2):108-113
Year
1996
Research Committee(s)
Melanoma
Study Number(s)
SWOG-8921

Evaluation of cisplatin, carboplatin, and etoposide in metastatic nonsmall cell lung carcinoma: A phase II study of the Southwest Oncology Group.

Authors
RA Figlin;JJ Crowley;EL Jacobs;M Muirhead;JW Goodwin;JJ Rinehart;RB Livingston
Journal / Conference
Cancer 78(5):998-1003
Year
1996
Research Committee(s)
Lung
Study Number(s)
SWOG-9127